Lutterbach Johannes, Sauerbrei Willi, Guttenberger Roland
Department of Radiotherapy, Radiologic University Hospital, Freiburg i. Br., Germany.
Strahlenther Onkol. 2003 Jan;179(1):8-15. doi: 10.1007/s00066-003-1004-5.
To identify prognostic factors for overall survival in patients with newly diagnosed glioblastoma undergoing radiation therapy.
From January 1980 to June 2000, we treated 432 consecutive patients with glioblastoma at out institution. 17 patients were excluded from the analysis for various reasons. Mean age of the 415 patients who were included in the study was 59 years (19-81 years), Karnofsky performance status (KPS) was > or = 70 in 280 patients. 343 patients underwent resection, 72 had a biopsy. Various fractionation schemes were used (conventional fractionation, n = 112; hypofractionation, n = 94; accelerated hyperfractionation, n = 209). Survival probabilities were estimated using the method of Kaplan and Meier. Multivariate analysis was done with a Cox regression model.
By July 2001, 406 patients had died. Medial overall survival was 8.2 months. Of ten factors considered in a proportional hazards model stratified for treatment (fractionation scheme and type of surgery), significant variables in a multivariate model were age (50-64 years vs < 50 years [RR 1.35; 95% CI 1.02-1.78], > or = 65 years vs < 50 years [RR 2.08; 95% CI 1.54-2.81]), performance status (KPS < 70 vs > or = 70 [RR 1.53; 95% CI 1.23-1.90]), and central tumor location (yes vs no [RR 1.39; 95% CI 1.04-1.87]). Blood hemoglobin (Hb) values were available in 318 patients and serum lactate dehydrogenase (LDH) levels in 234 patients. 89 patients were anemic (Hb men < 13 g/dl, women < 12 g/dl), in 80 patients the LDH level was raised beyond the upper limit of the normal range (> 240 U/l). By including the three significant variables, both parameters had an additional significant effect with an estimated relative risk of about 1.4 in their corresponding subgroups.
Besides established prognostic factors, anemia and raised serum LDH levels may negatively influence outcome in glioblastoma patients. Our results from data-dependent modeling have to be confirmed by independent studies.
确定新诊断的胶质母细胞瘤患者接受放射治疗后的总生存预后因素。
1980年1月至2000年6月,我们机构连续治疗了432例胶质母细胞瘤患者。17例患者因各种原因被排除在分析之外。纳入研究的415例患者的平均年龄为59岁(19 - 81岁),280例患者的卡氏评分(KPS)≥70。343例患者接受了手术切除,72例进行了活检。采用了各种分割方案(常规分割,n = 112;超分割,n = 94;加速超分割,n = 209)。使用Kaplan - Meier方法估计生存概率。采用Cox回归模型进行多因素分析。
到2001年7月,406例患者死亡。中位总生存期为8.2个月。在根据治疗分层的比例风险模型中考虑的10个因素(分割方案和手术类型)中,多因素模型中的显著变量为年龄(50 - 64岁与<50岁相比[风险比(RR)1.35;95%置信区间(CI)1.02 - 1.78],≥65岁与<50岁相比[RR 2.08;95% CI 1.54 - 2.81])、功能状态(KPS<70与≥70相比[RR 1.53;95% CI 1.23 - 1.90])以及肿瘤位于中央(是与否相比[RR 1.39;95% CI 1.04 - 1.87])。318例患者有血红蛋白(Hb)值,234例患者有血清乳酸脱氢酶(LDH)水平。89例患者贫血(男性Hb<13 g/dl,女性Hb<12 g/dl),80例患者的LDH水平高于正常范围上限(>240 U/l)。纳入这三个显著变量后,两个参数在其相应亚组中具有额外的显著影响,估计相对风险约为1.4。
除了已确定的预后因素外,贫血和血清LDH水平升高可能对胶质母细胞瘤患者的预后产生负面影响。我们基于数据建模的结果必须通过独立研究来证实。